GlaxoSmithKline(GSK)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE 100

Market Cap

£66,732m

Change Today

Price Down-2.50p

Share Price

1,275.50p

Detailed GlaxoSmithKline Share Price Data

Share Price 1,275.50p Price Down Close 1,278.00p
Change Today -2.50p Volume 9,953,912
Percent Change -0.20% Day High / Low 1,294.00p / 1,267.50p
Update Time 15:18:12 Year High / Low 1,385.00p / 1,001.00p
Bid 1,275.00p Last Trade Price 1,275.50p
Offer 1,275.50p Last Trade Amount 667
Open 1,279.50p Last Trade Time 15:18:12

Detailed GlaxoSmithKline Share Price Changes

Period Price Change Percent Change
1 week 1,288.00p -10.00p -0.78%
1 month 1,248.50p +29.50p +2.36%
3 months 1,102.00p +176.00p +15.97%
6 months 1,093.00p +185.00p +16.93%
1 year 1,315.00p -37.00p -2.81%

Additional GlaxoSmithKline Share Price Data

Ex-Marker Code Ex-Dividend NMS 8,000
Ex-Marker Start 30-Jul-08 VWAP 1,280.85p
Ex-Marker End 09-Oct-08 Beta 0.58

Related Market Prices

Index / Sector Value Change Percent Change
FTSE 100 5,294.20 -67.90 -1.27%
FTSE 350 2,762.40 -36.70 -1.31%
FTSE All-Share 2,705.54 -35.77 -1.30%
FTSEurofirst 300 1,134.42 -16.88 -1.47%
Pharmaceuticals & Biotechnology 8,309.90 -22.20 -0.27%
techMARK 1,419.29 -17.60 -1.22%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,275.50p Price Down
Change Today -2.50p
52 Week High 1,385.00p
52 Week Low 1,001.00p
Volume 9,953,912
Shares Issued 5,232m
Market Cap £66,732m
Beta 0.58
RiskGrade 122

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.75% below the market average68.75% below the market average68.75% below the market average68.75% below the market average68.75% below the market average
50.62% above the sector average50.62% above the sector average50.62% above the sector average50.62% above the sector average50.62% above the sector average
Price Trend
56.23% above the market average56.23% above the market average56.23% above the market average56.23% above the market average56.23% above the market average
61.80% above the sector average61.80% above the sector average61.80% above the sector average61.80% above the sector average61.80% above the sector average
Income
24.51% above the market average24.51% above the market average24.51% above the market average24.51% above the market average24.51% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
64.36% below the market average64.36% below the market average64.36% below the market average64.36% below the market average64.36% below the market average
80.56% below the sector average80.56% below the sector average80.56% below the sector average80.56% below the sector average80.56% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 14
Sell 7
Strong Sell 3
Total 31
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 30-Jul-08 30-Apr-08
Paid 09-Oct-08 10-Jul-08
Amount 13.00p 13.00p

Trades for 05-Sep-2008

Time Volume / Share Price
15:18 667 @ 1,275.50p
15:18 76 @ 1,275.50p
15:18 233 @ 1,275.50p
15:17 615 @ 1,275.50p
15:17 925 @ 1,275.50p

GlaxoSmithKline Key Personnel

CEO Jean-Pierre Garnier
CFO Julian Heslop
Chair Moncef Slaoui

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).